[Glycosaminoglycans in the synovial fluid of chronic joint diseases (proceedings)].
D001168:Arthritis / Q000378:metabolism*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000378:metabolism; D002809:Chondroitin Sulfates / Q000032:analysis; D005260:Female; D005634:Fructose-Bisphosphate Aldolase / Q000032:analysis; D006801:Humans; D006820:Hyaluronic Acid / Q000032:analysis*; D007136:Immunoglobulins / Q000032:analysis; D007958:Leukocyte Count; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage; D013582:Synovial Fluid / Q000032:analysis*; D014783:Viscosity
D007136:Immunoglobulins; D006820:Hyaluronic Acid; D002809:Chondroitin Sulfates; D011239:Prednisolone; D005634:Fructose-Bisphosphate Aldolase
Die Glykosaminoglykane in der Synovialflüssigkeit bei chronischen Gelenkerkrankungen